Increased expression and activity of CCL2 and CXCL12 has been reported in both the localized prostate cancer and within the microenvironment of bone metastases [13-18], while prior work from our own group has confirmed elevated CXCL8 expression in human prostate cancer tissue [19]. This evidence concerns the gene CXCL12 and prostate cancer.